Retatrutide is a newly developed drug that acts as a powerful GLP-1 receptor agonist. This innovative treatment holds significant potential for regulating type 2 diabetes. By replicating the actions of natural GLP-1, Retatrutide improves insulin secretion and suppresses glucagon release, leading to improved blood sugar control. Clinical trials have… Read More